Proposed HIV testing pathway could help show usefulness of new drugs
This article was originally published in Scrip
Executive Summary
The Forum for Collaborative HIV Research has released a new scientific paper that lays out a different approach for conducting Phase III HIV trials. The new protocols have been proposed to allow the efficacy and safety signals from any new agent to be more readily recognised in HIV by allowing them to be isolated from the complex 'standards of care' for HIV infections which usually involve three or more approved compounds.